Rivotril · DIN 00382841 · 2 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Rivotril · DIN 00382841
Manufacturer: Hoffmann-La Roche Limited; listing date 1996-10-01
Health Canada: Marketed since 2023-01-31 · brand RIVOTRIL · ATC N03AE01 CLONAZEPAM · form Tablet · route Oral · ingredients CLONAZEPAM 2 MG · company Cheplapharm arzneimittel gmbh · schedule Targeted substances (cdsa iv)
Ministry pays: $0.0721 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00382841)
Source record
DIN 00382841: Rivotril
Raw flags: sec3=Y
Item: 281200031; group id 426; item number 1060; lccId None; manufacturer id HLR
Source form: Tab; strength: 2mg
Recorded listing: General benefit
Source prices (unrounded): $0.5010; ministry $0.0721
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00382841
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2569
Interchangeable products
Apo-Clonazepam · DIN 02177897 · $0.0721
PMS-Clonazepam · DIN 02048736 · $0.0721
Teva-Clonazepam · DIN 02239025 · $0.0721
Shortage status: resolved shortage (ended March 31, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00382841
Shortage record checked October 6, 2026